ALK FISH rearranged and amplified tumor with negative immunohistochemistry: a rare and challenging case concerning ALK status screening in lung cancer.
Inserm, U1078, Brest Department of Pathology, CHRU Brest, University Hospital Morvan, Brest European University of Brittany, Rennes arnaud.uguen@chu-brest.fr.
A
A
Uguen
Department of Pathology, CHRU Brest, University Hospital Morvan, Brest European University of Brittany, Rennes EA4685, Brest University, Brest.
M
M
Talagas
Department of Pathology, CHRU Brest, University Hospital Morvan, Brest.
S
S
Andrieu-Key
Department of Pathology, CHRU Brest, University Hospital Morvan, Brest.
S
S
Costa
Department of Pathology, CHRU Brest, University Hospital Morvan, Brest.
I
I
Quintin-Roué
Inserm, U1078, Brest European University of Brittany, Rennes Cytogenetics and Reproduction Biology Laboratory, CHRU Brest, Brest, France.
M
M
De Braekeleer
Department of Pathology, CHRU Brest, University Hospital Morvan, Brest European University of Brittany, Rennes EA4685, Brest University, Brest.
P
P
Marcorelles
D000230:Adenocarcinoma / Q000235:genetics*; D005260:Female; D005455:Fluorescent Antibody Technique / Q000379:methods*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D020794:Receptor Protein-Tyrosine Kinases / Q000032:analysis* / Q000037:antagonists & inhibitors*
D020794:Receptor Protein-Tyrosine Kinases